[HTML][HTML] Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management

S Sukumar, B Lämmle, SR Cataland - Journal of clinical medicine, 2021 - mdpi.com
Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy
characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and …

[HTML][HTML] Platelet activation mechanisms and consequences of immune thrombocytopenia

S Sun, RT Urbanus, H Ten Cate, PG de Groot… - Cells, 2021 - mdpi.com
Autoimmune disorders are often associated with low platelet count or thrombocytopenia. In
immune-induced thrombocytopenia (IIT), a common mechanism is increased platelet …

[HTML][HTML] ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

XL Zheng, SK Vesely, SR Cataland, P Coppo… - Journal of Thrombosis …, 2020 - Elsevier
Background Despite advances in treatment options for thrombotic thrombocytopenic purpura
(TTP), there are still limited high quality data to inform clinicians regarding its appropriate …

[HTML][HTML] ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura

XL Zheng, SK Vesely, SR Cataland, P Coppo… - Journal of Thrombosis …, 2020 - Elsevier
Background Despite an increase in our understandings of pathogenesis of thrombotic
thrombocytopenic purpura (TTP), the approaches for initial diagnosis and management of …

[HTML][HTML] Recombinant ADAMTS13 for hereditary thrombotic thrombocytopenic purpura

LM Asmis, A Serra, A Krafft, A Licht… - … England Journal of …, 2022 - Mass Medical Soc
A 27-year-old patient with a history of severe obstetrical complications and arterial
thrombosis received a diagnosis of hereditary thrombotic thrombocytopenic purpura (TTP) …

Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells

F Ferraresso, AW Strilchuk, LJ Juang… - Molecular …, 2022 - ACS Publications
Ionizable cationic lipids are essential for efficient in vivo delivery of RNA by lipid
nanoparticles (LNPs). DLin-MC3-DMA (MC3), ALC-0315, and SM-102 are the only ionizable …

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura

M Scully, A Antun, SR Cataland, P Coppo… - … England Journal of …, 2024 - Mass Medical Soc
Background Congenital thrombotic thrombocytopenic purpura (TTP) results from severe
hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and …

Hereditary thrombotic thrombocytopenic purpura

JA Kremer Hovinga, JN George - New England Journal of …, 2019 - Mass Medical Soc
Hereditary Thrombotic Thrombocytopenic Purpura Hereditary thrombotic thrombocytopenic
purpura is an autosomal recessive disorder caused by the absence of a functional protease …

Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura

E Tarasco, L Bütikofer, KD Friedman… - Blood, The Journal …, 2021 - ashpublications.org
Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare thrombotic
microangiopathy characterized by severe congenital ADAMTS13 deficiency and recurring …

Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors

H Upreti, J Kasmani, K Dane… - Blood, The Journal …, 2019 - ashpublications.org
With timely and effective treatment, most patients with thrombotic thrombocytopenic purpura
(TTP) survive the acute TTP episode. In addition to the risk of relapse, TTP survivors have …